18 November 2025   Emulate, Inc.  the pioneer of organ-on-a-chip technology, announces the launch of its Brain-Chip R1 platform, marketed as a first-in-class comprehensive model of the neurovascular unit. This latest organ-on-chip model provides the means for human-relevant drug discovery, assessment of drug transport across the blood-brain barrier (BBB), and investigation of mechanisms of neuroinflammation.   This is particularly important since human neurological diseases,

12 November 2025   Inventia Life Science's 3D bioprinted patient-derived cancer models has opened the door for Hunter Medical Research Institute to advance its drug repurposing program into Australian New Zealand clinical trials .   The drug in question, efavirenz, is known as an antiretroviral NNRTI (non‑nucleoside reverse transcriptase inhibitor) used for treating HIV. Its repurposing has the potential to improve the survival of patients with high-grade serous ovarian cance